JP3213470B2 - 組換えインヒビン - Google Patents

組換えインヒビン

Info

Publication number
JP3213470B2
JP3213470B2 JP05450094A JP5450094A JP3213470B2 JP 3213470 B2 JP3213470 B2 JP 3213470B2 JP 05450094 A JP05450094 A JP 05450094A JP 5450094 A JP5450094 A JP 5450094A JP 3213470 B2 JP3213470 B2 JP 3213470B2
Authority
JP
Japan
Prior art keywords
inhibin
subunit
amino acid
acid sequence
embedded image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP05450094A
Other languages
English (en)
Japanese (ja)
Other versions
JPH07188296A (ja
Inventor
フオレイジ，ロバート・グレゴリー
スチワート，アンドリユー・ジヨージ
ロバートソン，デイヴイツト・マーク
デ・クレツツアー，デイヴイツト・モリツツ
フィンドレイ，ジョン・ケール
Original Assignee
バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド
モナシユ・ユニバーシテイー
モナッシュ・メディカル・センター
セント・ヴインセンツ・インステイチユート・オブ・メデイカル・リサーチ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27507359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP3213470(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド, モナシユ・ユニバーシテイー, モナッシュ・メディカル・センター, セント・ヴインセンツ・インステイチユート・オブ・メデイカル・リサーチ filed Critical バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド
Publication of JPH07188296A publication Critical patent/JPH07188296A/ja
Application granted granted Critical
Publication of JP3213470B2 publication Critical patent/JP3213470B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP05450094A 1985-04-18 1994-02-28 組換えインヒビン Expired - Lifetime JP3213470B2 (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
AUPH019485 1985-04-18
AUPH232085 1985-09-06
AUPH315785 1985-10-29
AUPH396085 1985-12-19
AU3961 1985-12-20
AUPH396185 1985-12-20
AU0194 1985-12-20
AU3960 1985-12-20
AU3157 1985-12-20
AU2320 1995-04-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP61503001A Division JP2652534B2 (ja) 1985-04-18 1986-04-14 組換えインヒビン

Publications (2)

Publication Number Publication Date
JPH07188296A JPH07188296A (ja) 1995-07-25
JP3213470B2 true JP3213470B2 (ja) 2001-10-02

Family

ID=27507359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP05450094A Expired - Lifetime JP3213470B2 (ja) 1985-04-18 1994-02-28 組換えインヒビン

Country Status (11)

Country Link
US (1) US6613891B1 (2)
EP (1) EP0218717B1 (2)
JP (1) JP3213470B2 (2)
KR (1) KR940004077B1 (2)
CA (1) CA1341619C (2)
DE (1) DE3650689T2 (2)
DK (1) DK173446B1 (2)
IL (1) IL78519A (2)
IN (1) IN165453B (2)
NZ (1) NZ215829A (2)
WO (1) WO1986006076A1 (2)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
AU599373B2 (en) * 1986-03-13 1990-07-19 Biotechnology Australia Proprietary Limited Method of assay of inhibin
WO1988000208A1 (en) * 1986-06-24 1988-01-14 The Salk Institute For Biological Studies Ovine inhibin
EP0368992B1 (en) * 1988-05-31 1995-02-15 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
US6043212A (en) * 1993-07-26 2000-03-28 Cor Therapeutics, Inc. Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
AU8579298A (en) * 1997-07-31 1999-02-22 Johns Hopkins University School Of Medicine, The Growth differentiation factor-16
EP1163365A4 (en) 1999-02-25 2002-11-20 Auckland Uniservices Ltd DIAGNOSIS AND THERAPY OF EARLY OVARY FAILURE
EP1389997B1 (en) * 2001-04-13 2010-12-08 Boyce Thompson Institute For Plant Research Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
CN102409065B (zh) * 2011-06-28 2014-05-21 中国农业科学院北京畜牧兽医研究所 一种提高动物繁育力的新型shRNA及其应用
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN105296493B (zh) * 2015-11-13 2020-09-11 北京农学院 一种牛抑制素α亚基成熟肽基因及重组表达蛋白质的方法
CN108588100B (zh) * 2018-05-09 2021-07-16 广州市达瑞生物技术股份有限公司 一种抑制素b双基因片段联合表达载体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4717666A (en) 1984-03-05 1988-01-05 Smithkline Beckman Corporation Cloned streptomycete lividans excretable β-galactosidase gene
JPS60501592A (ja) 1983-06-20 1985-09-26 バッテル・メモリアル・インスティチュート 高速マルチソリツド流動床法
US4643969A (en) 1983-07-25 1987-02-17 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
EP0154434B1 (en) * 1984-02-17 1993-01-27 Genentech, Inc. Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
CA1341617C (en) 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0730114B2 (ja) * 1985-04-03 1995-04-05 正雄 五十嵐 インヒビン
US4624944A (en) 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
US4798885A (en) 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4737578A (en) 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ＦＥＢＳ ＬＥＴＴＥＲＳ，Ｖｏｌ．１７５，Ｎｏ．２，ｐ．３４９−３５５（１９８４）

Also Published As

Publication number Publication date
EP0218717A4 (en) 1990-04-10
NZ215829A (en) 1991-11-26
US6613891B1 (en) 2003-09-02
DE3650689T2 (de) 1999-04-08
WO1986006076A1 (en) 1986-10-23
DK611386D0 (da) 1986-12-18
IL78519A (en) 1992-01-15
EP0218717B1 (en) 1998-07-15
DK173446B1 (da) 2000-11-06
CA1341619C (en) 2011-08-02
KR870700633A (ko) 1987-12-30
KR940004077B1 (ko) 1994-05-11
DE3650689D1 (de) 1998-08-20
IN165453B (2) 1989-10-21
IL78519A0 (en) 1986-08-31
JPH07188296A (ja) 1995-07-25
DK611386A (da) 1987-02-18
EP0218717A1 (en) 1987-04-22

Similar Documents

Publication Publication Date Title
JP3213470B2 (ja) 組換えインヒビン
AU620673B2 (en) Somatotropin analogs
US20100203060A1 (en) Inhibitors for growth hormone and related hormones, and methods of use thereof
JP2000078991A (ja) ヒト・ナトリウム依存性リン酸輸送体（ｉｐｔ―１）
KR20000029911A (ko) ＧｎＲＨ-류코톡신키메라
KR100293025B1 (ko) 고나도트로핀방출호르몬에대한면역원성캐리어시스템
US7026156B1 (en) Diagnostic and protective antigen gene sequences of ichthyophthirius
JP2002526073A (ja) 新規のヒト生長分化因子のコード配列、そのｄｎａ配列によりコードされるポリペプチド、およびこれらの製造方法。
JPH07503142A (ja) 免疫避妊剤及び方法
EA001201B1 (ru) Пептиды антисекреторного фактора, регулирующие патологические изменения проницаемости
RU2130072C1 (ru) Фрагмент днк, кодирующий иммуногенный поверхностный полипептид мерозоитов, иммуногенный полипептид (варианты) и способ его получения, рекомбинантная плазмидная днк и способ ее получения, способ получения рекомбинантного вируса вакцины, способ получения микроорганизма, вакцина против кокцидиоза птицы
MC2227A1 (fr) Procede pour preparer une proteine ayant un ou plusieurs determinants immunoreactifs et/ou antigeniques de l'antigene de surface des merozoites d'eimeria,adn codant pour cette proteine,procede de preparation d'un vecteur recombinant comprenant cet adn,procede de preparation d'un microorganisme transforme contenant ce vecteur recombinant et procede pour preparer un vaccin protegeant les volailles contre la coccidiose
JPH05500654A (ja) クローン化透明帯遺伝子を基本とする避妊ワクチン
US6911206B1 (en) Fusion proteins comprising carriers that can induce a dual immune response
JPH1142092A (ja) ヒト心臓／脳トロイド様タンパク質
RU2668174C2 (ru) Суперагонисты гликопротеинового гормона длительного действия
JP2652534B2 (ja) 組換えインヒビン
CZ20004256A3 (cs) Indukce antibiotických proteinů a peptidů LAIT/sCD14-proteinem
AU5903986A (en) Recombinant inhibin
EP0492179A2 (en) Avian growth hormone receptor and binding protein
US6413521B1 (en) Helminth parasite antigen with aminopeptidase-like activity
US7544485B2 (en) Baldness related gene and the polypeptide encoded thereby, and uses
CN100415299C (zh) 胚泡着床相关因子及其用途
FR2565599A1 (fr) Sequence d'adnc codant pour la beta fsh porcine, vecteur la comprenant, beta fsh produite et son utilisation
KR100226985B1 (ko) 신규한 인간성장호르몬방출인자-인간상피세포성장인자 융합유전자, 이의 발현벡터 및 이를 이용한 인간성장호르몬방출인자의 제조방법

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term